J&J | Денежные Средства И Эквиваленты

Cash And Equivalent Изменить Дата
AbbVie USD 13.29B 4.53B 2023-09
Amgen USD 10.94B 23.8B 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Baxter International USD 3.19B 2.59B 2023-12
Bayer EUR 6.82B 2.33B 2023-09
Becton, Dickinson and Co. USD 1.18B 236M 2023-12
Cooper Companies USD 135.2M 14.4M 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Globus Medical USD 467.29M 187.67M 2023-12
Hologic USD 1.93B 790.4M 2023-12
Insulet USD 547M 100M 2023-12
Integra LifeSciences USD 276.4M 2.67M 2023-12
Merit Medical Systems USD 587.04M 528.36M 2023-12
Pfizer USD 3.15B 516M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Stryker USD 2.94B 1.08B 2023-12
Tandem Diabetes Care USD 58.87M 20.74M 2023-12
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09
Zimmer Biomet Holdings USD 415.8M 123.7M 2023-12
Zoetis USD 2.04B 288M 2023-12



J&J Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Apr 2024.